{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:24:39Z","timestamp":1783329879325,"version":"3.54.6"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Many countries saw an increase in invasive infections caused by\n                      <jats:italic toggle=\"yes\">Streptococcus pyogenes<\/jats:italic>\n                      (iGAS) late 2022 to early 2023. Several hypotheses have been put forward to explain this increase, but thus far, reports have been limited to the immediate post-pandemic period, and the relative contribution of each of those factors remains unknown.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We describe the epidemiology of iGAS in Belgium in children below 5 years of age from January 2014 until December 2024 based on laboratory data from the National Reference Centre. Using a cointegration analysis after removing seasonality, we formally assess the influence of co-circulating viral diseases varicella, respiratory syncytial virus and influenza on iGAS case numbers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      After very low levels during the pandemic years, a marked increase started in June 2022, reaching an all-time high in April 2023 before decreasing but still remaining at high levels in early 2024. Reduced population immunity alone cannot explain this pattern.\n                      <jats:italic toggle=\"yes\">Emm<\/jats:italic>\n                      12,\n                      <jats:italic toggle=\"yes\">emm<\/jats:italic>\n                      1 and\n                      <jats:italic toggle=\"yes\">emm<\/jats:italic>\n                      3 genotypes succeeded each other as the predominant genotype, indicating a complex interplay of transmission and virulence factors. Levels of varicella infections, but not respiratory syncytial virus or influenza, are closely linked to the increase in iGAS levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Levels of iGAS infections remained high up to 2 years after lifting nonpharmaceutical interventions, and this increase is undoubtedly multifactorial. Continued high-quality surveillance is required to follow up the situation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005165","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:00:33Z","timestamp":1769576433000},"page":"677-683","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Continued High Levels of Invasive Streptococcus pyogenes Infections in Belgian Children Under 5 Years: Exploring Different Contributing Factors"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4550-9439","authenticated-orcid":false,"given":"Laura","family":"Cornelissen","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"De Keersmaeker","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5267-5080","authenticated-orcid":false,"given":"Sien","family":"De Koster","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Belgian Reference Centre for S. pyogenes and Other Invasive \u03b2-Hemolytic Streptococci Non-group B, University Hospital Antwerp, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"van Kleef-van Koeveringe","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Belgian Reference Centre for S. pyogenes and Other Invasive \u03b2-Hemolytic Streptococci Non-group B, University Hospital Antwerp, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Matheeussen","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Belgian Reference Centre for S. pyogenes and Other Invasive \u03b2-Hemolytic Streptococci Non-group B, University Hospital Antwerp, Edegem, Belgium"},{"name":"Departments of Medical Microbiology Medical Biochemistry, University of Antwerp, Wilrijk, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2642-9919","authenticated-orcid":false,"given":"Pierre R.","family":"Smeesters","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Brussels University Hospital, Academic Children Hospital Queen Fabiola, Universit\u00e9 libre de Bruxelles, Brussels, Belgium"},{"name":"Molecular Bacteriology Laboratory, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"R1-20260706","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of group A Streptococcus.","volume":"27","author":"Walker","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"R2-20260706","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00068-021-01706-z","article-title":"Prognostic factors for mortality in 123 severe cases of necrotizing fasciitis in 5 hospitals in the Netherlands between 2003 and 2017.","volume":"48","author":"van Stigt","year":"2022","journal-title":"Eur J Trauma Emerg Surg"},{"key":"R3-20260706","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases.","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R4-20260706","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1111\/1469-0691.12134","article-title":"Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study.","volume":"19","author":"McMillan","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"R5-20260706","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-022-00593-8","article-title":"Correlates of immunity to group A Streptococcus: a pathway to vaccine development.","volume":"8","author":"Frost","year":"2023","journal-title":"npj Vaccines"},{"key":"R6-20260706","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1348-0421.12577","article-title":"Pathogenic mechanisms of invasive group A Streptococcus infections by influenza virus-group A Streptococcus superinfection.","volume":"62","author":"Okamoto","year":"2018","journal-title":"Microbiol Immunol"},{"key":"R7-20260706","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1473-3099(06)70466-2","article-title":"Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness.","volume":"6","author":"Brundage","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R8-20260706","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/irv.12658","article-title":"Associations between common respiratory viruses and invasive group A streptococcal infection: a time-series analysis.","volume":"13","author":"de Gier","year":"2019","journal-title":"Influenza Other Respir Viruses"},{"key":"R9-20260706","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1086\/428614","article-title":"Varicella-associated invasive group A streptococcal disease in Alberta, Canada\u20142000\u20132002.","volume":"40","author":"Tyrrell","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R10-20260706","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group a streptococcal infections in the varicella vaccine era.","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"key":"R11-20260706","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1469-0691.2007.01706.x","article-title":"Paediatric varicella hospitalisations in France: a nationwide survey.","volume":"13","author":"Grimprel","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"R12-20260706","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad188","article-title":"Unexpected increase in invasive group A streptococcal infections in children after respiratory viruses outbreak in France: a 15-year time-series analysis.","volume":"10","author":"Lassoued","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"R13-20260706","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1473-3099(22)00865-9","article-title":"Can group A streptococcus infections be influenced by viruses in the respiratory tract?","volume":"23","author":"Turner","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"R14-20260706","doi-asserted-by":"crossref","first-page":"2200941","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200941","article-title":"Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022.","volume":"28","author":"de Gier","year":"2023","journal-title":"Euro Surveill"},{"key":"R15-20260706","doi-asserted-by":"crossref","first-page":"2200942","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200942","article-title":"Increase in invasive group A streptococcal infection notifications, England, 2022.","volume":"28","author":"Guy","year":"2023","journal-title":"Eurosurv"},{"key":"R16-20260706","doi-asserted-by":"crossref","first-page":"2400242","DOI":"10.2807\/1560-7917.ES.2024.29.20.2400242","article-title":"Increase in invasive group A streptococcal infections (iGAS) in children and older adults, Norway, 2022 to 2024.","volume":"29","author":"Valcarcel Salamanca","year":"2024","journal-title":"Euro Surveill"},{"key":"R18-20260706","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S1473-3099(19)30446-3","article-title":"Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study.","volume":"19","author":"Lynskey","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R21-20260706","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1073\/pnas.1523941113","article-title":"Digital epidemiology reveals global childhood disease seasonality and the effects of immunization.","volume":"113","author":"Bakker","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-20260706","doi-asserted-by":"crossref","first-page":"e0160429","DOI":"10.1371\/journal.pone.0160429","article-title":"Surveillance of infectious diseases by the sentinel laboratory network in Belgium: 30 years of continuous improvement.","volume":"11","author":"Muyldermans","year":"2016","journal-title":"PLoS One"},{"key":"R25-20260706","doi-asserted-by":"crossref","first-page":"1900627","DOI":"10.2807\/1560-7917.ES.2020.25.39.1900627","article-title":"Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018\/19.","volume":"25","author":"Subissi","year":"2020","journal-title":"Euro Surveill"},{"key":"R26-20260706","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2307\/1913236","article-title":"Co-Integration and error correction: representation, estimation, and testing.","volume":"55","author":"Engle","year":"1987","journal-title":"Econometrica"},{"key":"R27-20260706","doi-asserted-by":"crossref","first-page":"107982","DOI":"10.1016\/j.ijid.2025.107982","article-title":"Sharp increase in the incidence and severity of invasive Streptococcus pyogenes infections in children after the COVID-19 pandemic (2019-2023): a nationwide multicenter study.","volume":"159","author":"Cobo-V\u00e1zquez","year":"2025","journal-title":"Int J Infect Dis"},{"key":"R28-20260706","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2352-4642(23)00295-X","article-title":"Invasive group A streptococcal infections in children and adolescents in Denmark during 2022-23 compared with 2016-17 to 2021-22: a nationwide, multicentre, population-based cohort study.","volume":"8","author":"Nygaard","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"R29-20260706","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10096-023-04568-y","article-title":"Incidence and clinical and microbiological features of invasive and probable invasive streptococcal group A infections in children and adults in the Brussels-Capital Region, 2005\u20132020.","volume":"42","author":"Zangarini","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R30-20260706","doi-asserted-by":"crossref","first-page":"2300427","DOI":"10.2807\/1560-7917.ES.2023.28.36.2300427","article-title":"Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1UK and diverse emm12 isolates, Portugal, September 2022 to May 2023.","volume":"28","author":"Gouveia","year":"2023","journal-title":"Euro Surveill"},{"key":"R31-20260706","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1093\/infdis\/jiae611","article-title":"Decline of antibodies to major viral and bacterial respiratory pathogens during the COVID-19 pandemic.","volume":"231","author":"Lorenz","year":"2025","journal-title":"J Infect Dis"},{"key":"R32-20260706","doi-asserted-by":"crossref","first-page":"e2218959","DOI":"10.1001\/jamanetworkopen.2022.18959","article-title":"Association of nonpharmaceutical interventions during the COVID-19 pandemic with invasive pneumococcal disease, pneumococcal carriage, and respiratory viral infections among children in France.","volume":"5","author":"Rybak","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R33-20260706","doi-asserted-by":"crossref","first-page":"2300739","DOI":"10.2807\/1560-7917.ES.2024.29.40.2300739","article-title":"Attribution of invasive group A streptococcal infections (iGAS) to predisposing viral infections, the Netherlands, 2010 to 2023.","volume":"29","author":"de Gier","year":"2024","journal-title":"Euro Surveill"},{"key":"R34-20260706","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1038\/s41467-024-47929-7","article-title":"Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenes.","volume":"15","author":"Vieira","year":"2024","journal-title":"Nat Commun"},{"key":"R35-20260706","doi-asserted-by":"crossref","first-page":"e0076624","DOI":"10.1128\/jcm.00766-24","article-title":"Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009-2023, the Netherlands: a molecular epidemiological study.","volume":"62","author":"R\u00fcmke","year":"2024","journal-title":"J Clin Microbiol"},{"key":"R36-20260706","doi-asserted-by":"crossref","first-page":"2300422","DOI":"10.2807\/1560-7917.ES.2023.28.36.2300422","article-title":"Increase in bloodstream infections caused by emm1 group A Streptococcus correlates with emergence of toxigenic M1UK, Belgium, May 2022 to August 2023.","volume":"28","author":"Rodriguez-Ruiz","year":"2023","journal-title":"Euro Surveill"},{"key":"R37-20260706","doi-asserted-by":"crossref","first-page":"2300291","DOI":"10.2807\/1560-7917.ES.2023.28.26.2300291","article-title":"Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023.","volume":"28","author":"Johannesen","year":"2023","journal-title":"Euro Surveill"},{"key":"R38-20260706","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.meegid.2009.03.002","article-title":"Population biology of the human restricted pathogen, Streptococcus pyogenes.","volume":"9","author":"Bessen","year":"2009","journal-title":"Infect Genet Evol"},{"key":"R39-20260706","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/cid\/civ793","article-title":"Clinical and microbiological characteristics of invasive group A streptococcal infections before and after implementation of a universal varicella vaccine program.","volume":"62","author":"Fr\u00e8re","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R40-20260706","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/jpids\/piz013","article-title":"Invasive group A streptococcus infection in children in Southern Israel before and after the introduction of varicella vaccine.","volume":"9","author":"Hasin","year":"2020","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:00:30Z","timestamp":1783328430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005165","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}